How Usen was paid
$22,917 in total for 2024, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Bonus | Total |
|---|---|---|---|
| Todd UsenChief Executive Officer | $22,917 | — | $22,917 |
| Olav BergheimFormer President and Chief Executive Officer | — | — | — |
| Hakon BergheimFormer Chief Operating Officer | $323,621 | $48,543 | $372,164 |
| John DahldorfFormer Chief Financial Officer | $425,000 | $67,575 | $492,575 |
What changed and why
- $22,917Todd Usen joined as Chief Executive Officer on December 13, 2024, earning $22,917 in total compensation for the year.
- Bonus amounts paid to eligible executive officers were lower than target opportunities due to below-target corporate performance.
- Willis Towers Watson was retained in 2024 as an independent compensation consultant to evaluate executive and non-executive director compensation programs.
- No equity incentive awards were granted to named executive officers during the remainder of 2024 following the Business Combination.
- The 2024 Equity Incentive Plan authorizes the issuance of up to 4,472,593 shares of Common Stock as an initial share reserve.
Other Adagio Medical Holdings proxy statements
- 2026 proxy statement
Todd Usen paid $2.5M.
Filed Apr 30, 2026
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.